Company Information

  

Address: AZRIELI TRIANGLE BUILDING
132 DERECH MENACHEM BEGIN, 39TH FLOOR 
City: TEL AVIV 
State:  
Zip Code: 6701101 
Telephone: 972722204661 

Description of Business

Primary SIC Code: 2834
(As filed with the SEC)  

We are an Israeli corporation based in Tel Aviv and were incorporated in 2008. Our principal executive offices are located at Azrieli Triangle Building, 132 Derech Menachem Begin, 39th Floor, Tel Aviv 6701101 Israel, and our telephone number is +972 72 220 4661. Our website address is www.alcobra-pharma.com. The information contained on, or that can be accessed through, our website is not part of this form. We have included our website address herein solely as an inactive textual reference. We are an "emerging growth company," as defined in Section 2(a) of the Securities Act of 1933, or the Securities Act, as modified by the JOBS Act. As such, we are eligible to, and intend to, take advantage of certain exemptions from various reporting requirements applicable to other public companies that are not "emerging growth companies" such as not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002.  ... More ...  

Per Share Overview

Date 12-mos Rolling EPS Dividend P/E Ratio
12/2016-0.89NAN/E
09/2016-0.88NAN/E
06/2016-0.79NAN/E
12/2015-0.90NAN/E
06/2014-1.98NAN/E
12/2013-1.04NAN/E

Key Financial Ratios and Statistics

FYE: 12/31

Profitability 2016 Leverage 2016
Net Inc/Comm Equity-0.17Total Liab/Total Assets0.08
Net Inc/Total Assets-0.48Total Liab/Inv Cap0.09
Net Inc/Inv Cap-0.52Total Liab/Comm Equity0.03
Pretax Inc/Net SalesNAInterest Coverage RatioNA
Net Inc/Net SalesNACurr Debt/EquityNA
Cash Flow/Net SalesNALTD/EquityNA
SG&A/NetSalesNATotal Debt/EquityNA
Asset Utilization   Liquidity  
Net Receivables TurnoverNAQuick Ratio11.82
Inventory TurnoverNACurrent Ratio11.82
Inventory Day SalesNANet Rec/Curr AssetsNA
Net Sales/Work CapNAInv/Curr AssetsNA
Net Sales/PP&ENA  

Income Statement (Millions)

  12/31/2016 12/31/2015 12/31/2014 12/31/2013
Total Revenues(Net Sales) NA NA NA NA
Cost of Goods Sold NA NA NA NA
Selling & Admin Exps 6.78 6.24 7.97 3.22
Operating Income -25.17 -19.70 -33.08 -10.29
Interest Exp NA NA NA NA
Pretax Income -24.53 -19.40 -32.85 -10.49
Other Income 0.64 0.30 0.23 NA
Net Income Bef Extraordinary ... NA NA NA NA
Net Income -24.60 -19.45 -32.83 -10.55

Balance Sheet (Millions)

Assets 12/31/2016 12/31/2015 12/31/2014 12/31/2013
Cash & Short Term Investments 17.24 16.66 2.18 22.10
Receivables - Total NA NA NA 0.12
Inventories - Total NA NA NA NA
Total Current Assets 51.30 52.35 22.13 50.22
Net Property, Plant & Equipment 0.24 0.23 0.10 0.05
Total Assets 51.57 71.68 22.32 50.32
Liabilities        
Accounts Payable 4.34 2.35 2.38 1.64
Debt in Current Liabilities NA NA NA NA
Total Current Liabilities 4.34 2.35 2.38 1.64
Long-Term Debt NA NA NA NA
Total Liabilities 4.34 2.35 2.38 1.64
Stockholder's Equity        
Minority Interest NA NA NA NA
Preferred Stock NA NA NA NA
Common Stock 0.07 0.07 0.04 0.04
Retained Earnings -95.62 -71.02 -51.57 -18.73
Treasury Stock 0.00 0.00 0.00 0.00
Total Stockholders' Equity 47.23 69.33 19.94 48.69
Total Liabilities and Stockholders' Equity 51.57 71.68 22.32 50.32

Cash Flow Summary (Millions)

Categories 12/31/2016 12/31/2015 12/31/2014 12/31/2013
Net Cash Provided by Operating Activities -19.24 -18.15 -28.33 -7.35
Net Cash Provided by Investing Activities 4.88 -33.84 8.41 -28.05
Net Cash Provided by Financing Activities 0.01 66.47 0.00 57.40

Annual Summary Data (Millions)

Year Sales Net Income EPS
12/20120.00-1.58--
12/20130.00-10.55-1.04
12/20140.00-32.83--
12/20150.00-19.45-0.90
12/20160.00-24.60-0.89
Growth RatesNaN----

Stock Ownership

Type Date(Q,M) No. Owners Shares Held (000s) % Own
Institutional09/30/17378,83832.07




Report Date : 10/16/2017

Powered By Edgar Online © 2017EDGAR®Online, a division of Donnelley Financial Solutions. EDGAR® is a federally registered trademark of the U.S. Securities and Exchange Commission. EDGAR Online is not affiliated with or approved by the U.S. Securities and Exchange Commission.